TRP_1170x120_3-8-19

Alan Turfe

QS/1 honors pharmacists at NCPA

QS/1 honors pharmacists at NCPA

SPARTANBURG, S.C.— QS/1 realizes pharmacy is a noble profession that gives back to the community every day. For their work, QS/1 is honoring pharmacists at the 2018 National Community Pharmacists Association (NCPA) Annual Convention by donating to charities in the name of three pharmacists. “QS/1 stands with NCPA in supporting the efforts of community pharmacy,”

J M Smith realigns leadership team

J M Smith realigns leadership team

SPARTANBURG, S.C. — J M Smith Corp. has named Saul Factor to lead its drug wholesale business and Kevin Welch to head its pharmacy technology solutions business. J M Smith said Monday that Factor, previously president of the QS/1 pharmacy software unit, will now serve as president of drug distributors Smith Drug Co. and Burlington

QS/1’s PrimeCare moving to J M Smith’s Integra

QS/1’s PrimeCare moving to J M Smith’s Integra

SPARTANBURG, S.C. — QS/1’s PrimeCare long-term care pharmacy software is being transferred to fellow J M Smith Corp. division Integra LTC Solutions. J M Smith said transition is in process, with many of details still to be finalized with input from customers and staff at Integra and QS/1. With the shift, PrimeCare will fall under

QS/1 president Tammy Devine to retire

QS/1 president Tammy Devine to retire

SPARTANBURG, S.C. — Tammy Devine, president of pharmacy software firm QS/1, plans to retire later this year. QS/1 said Tuesday that it has begun a national search for a successor to Devine, who has served as president since 2011 and has been with the J M Smith Corp. subsidiary for 35 years. “The time is

New CEO Alan Turfe takes reins at J M Smith

New CEO Alan Turfe takes reins at J M Smith

SPARTANBURG, S.C. — J M Smith Corp. has named A. Alan Turfe as chairman and chief executive officer, succeeding William Cobb, who is retiring. The pharmaceutical distribution, health care and technology company — whose businesses include Smith Drug Co., QS/1, Integral Solutions Group, RxMedic Systems, Integra LTC Solutions and Burlington Drug Co. — said Wednesday